# Anil Kapoor

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/anil-kapoor/

## Facts

| Field | Value |
| --- | --- |
| Citations | 16,332 |
| Field | Renal cell carcinoma treatment |
| h-index | 55 |
| i10-index | 254 |
| Last Known Institution | People’s University |
| OpenAlex ID | https://openalex.org/A5013185325 |
| ORCID iD | https://orcid.org/0000-0001-9180-8029 |
| Works | 635 |

## Researcher papers

- [Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma](https://scholariq.org/papers/temsirolimus-interferon-alfa-or-both-for-advanced-renal-cell-carcinoma/)
- [Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-or-everolimus-for-advanced-renal-cell-carcinoma/)
- [Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study](https://scholariq.org/papers/lenvatinib-plus-pembrolizumab-versus-sunitinib-as-first-line-treatment-of/)

## Researcher topics

- [Renal cell carcinoma treatment](https://scholariq.org/topics/renal-cell-carcinoma-treatment/)
- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Prostate Cancer Treatment and Research](https://scholariq.org/topics/prostate-cancer-treatment-and-research/)
- [Multiple and Secondary Primary Cancers](https://scholariq.org/topics/multiple-and-secondary-primary-cancers/)

## Researcher university

- [People’s University](https://scholariq.org/institutions/people-s-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.